- Ciències Mèdiques Bàsiques
Departament
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red de Cáncer (23)
2024
-
Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease
Human Pathology, Vol. 143, pp. 50-61
-
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review
Cancers, Vol. 16, Núm. 1
-
RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis
iScience, Vol. 27, Núm. 4
2023
-
Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
Molecular Cancer, Vol. 22, Núm. 1
-
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs
International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165
-
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science, Vol. 10, Núm. 32
-
Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study
Cancers, Vol. 15, Núm. 22
-
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118
-
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
Cancer Communications
2022
-
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma
Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259
-
Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships
European Journal of Medical Genetics, Vol. 65, Núm. 11
-
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
Oncogene, Vol. 41, Núm. 13, pp. 1835-1850
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
-
Myosin Vb as a tumor suppressor gene in intestinal cancer
Oncogene, Vol. 41, Núm. 49, pp. 5279-5288
2021
2020
-
Copy-number alteration burden differentially impacts immune profiles and molecular features of hepatocellular carcinoma
Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6350-6361
2019
-
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
British Journal of Cancer, Vol. 121, Núm. 4, pp. 340-343
-
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis
Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85
2018
-
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth
Molecular Oncology, Vol. 12, Núm. 8, pp. 1383-1397